VitaNova Life Sciences (VNOV) EPS (Basic) Growth (3y) (2021 - 2026)
VitaNova Life Sciences (VNOV) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.60 Bn | 97.44 Bn | 3.69 Bn | 5.72% |
| 2 | Cencora | 61.76 Bn | 58.95 Bn | 3.61 Bn | 19.30% |
| 3 | Cardinal Health | 54.19 Bn | 49.33 Bn | 2.56 Bn | 319.32% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | -6.41% |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 155.55 Mn | 134.01 Mn | 7.34 Mn | -42.02% |
| 7 | Accendra Health | 93.18 Mn | 85.53 Mn | 263.41 Mn | -46.08% |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | -3.36% |
| 9 | Cosmos Health | 13.29 Mn | 10.85 Mn | 1.51 Mn | -3.51% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 68.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 68.90% |
| Jan 31, 2026 | -8.32% |
| Oct 31, 2025 | 47.85% |
| Jul 31, 2025 | -92.14% |
| Apr 30, 2025 | 108.07% |
| Jan 31, 2025 | 24.31% |
| Oct 31, 2024 | -20.07% |
| Jul 31, 2024 | -27.87% |
| Apr 30, 2024 | 87.45% |
| Jan 31, 2024 | 58.50% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -37.88% |
| Jul 31, 2022 | 28.21% |
| Oct 31, 2021 | 35.16% |
| Jul 31, 2021 | 122.45% |